Class 4 Caution in use-Trazodone 50mg/ml oral solution

Cygnus Pharma Ltd. Have informed MHRA that the European Article Number (EAN) barcode printed on various packs of Trazodone Hydrochloride 50mg/5ml Oral Solution, is defective and returns the incorrect information

MHRA drug alert date: 22nd May 2024

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-cygnus-pharma-ltd-trazodone-hydrochloride-50mg-slash-5ml-oral-solution-el-24-a-slash-16

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please email info@cygnuspharma.co.uk or telephone 01582 809833.

For stock control enquiries please email info@cygnuspharma.co.uk or telephone 01582 809833.

Class 4 caution in use-PI Keppra tablets 500mg

Doncaster Pharma Limited have identified an error relating to the Braille printed on the cartons on various parallel imported packs which have been repackaged by BModesto B.V.

MHRA drug alert date: 15th May 2024

MHRA Drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-doncaster-pharma-limited-keppra-500mg-film-coated-tablets-el-24-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=db11fb3d-2987-42ea-8b51-47915e1572c3&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information and stock control enquiries please contact Doncaster Pharma on tel. 01302 365 000, email quality.enquiries@doncasterpharma.co.uk or commercial@doncasterpharma.co.uk

Class 3 recall-Suprefact 1 mg/ml solution for injection

Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure. This is because the named batch of Suprefact 1mg/ml solution for injection is being distributed in packaging intended for the Canadian market by Cheplapharm, instead of the correct UK packaging by Neon Healthcare Ltd for Buserelin 1 mg/ml solution for injection.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-neon-healthcare-ltd-suprefact-1-mg-slash-ml-solution-for-injection-cheplapharm-canadian-livery-el-24-a-slash-14?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=4f978699-0d51-4e8b-8090-3b47f8abd279&utm_content=immediately

Further Information

For medical information or stock control enquiries please contact: Neon Healthcare Ltd via Medinfo@neonhealthcare.com or +44 (0) 1992 926 330

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Class 3 recall- Co-Codamol 8/500mg effervescent tablets (Key pharmaceuticals livery

Accord-UK Ltd is recalling a specific batch of Co-Codamol 8/500mg Effervescent Tablets (Key Pharmaceuticals Livery) as a precautionary measure due to the internal tablet blister strips being printed with an incorrect expiry date.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-uk-ltd-co-codamol-8-slash-500mg-effervescent-tablets-key-pharmaceuticals-livery-el-24-a-slash-12?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5bbfbb93-89fc-44d3-8872-098e5dc41b46&utm_content=immediately

Further Information

For medical information enquiries please contact Accord-UK Ltd’s Medical Information Department on 01271 385257, or email medinfo@accord-healthcare.com

For stock control enquiries please contact Accord-UK Ltd’s Customer Services Team on 0800 373573, or email customerservices@accord-healthcare.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall- OPDIVO 10 mg/mL concentrate for solution

Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML)

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-bristol-myers-squibb-pharmaceuticals-limited-opdivo-10-mg-slash-ml-concentrate-for-solution-for-infusion-nivolumab-el-24-a-slash-11

Further information

For medical information enquiries please contact the Bristol Myers Squibb Medical Information Department by phone (0800 731 1736) or email medical.information@bms.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Freeflex Sodium chloride 0.9%

Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.

MHRA drug alert date: 21st March 2024

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-fresenius-kabi-limited-sodium-chloride-intravenous-infusion-0-dot-9-percent-freeflex-el-24-a-slash-10

This is a caution in use only we are not accepting stock returns

Further information

For more information or medical information queries please email Medical.Information-UK@fresenius-kabi.com or telephone +44 (0)1928533575

For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758

Field safety notice-Carboflex dressings

Field safety notice-Carboflex dressings

We have received a recall from Convatec regarding two sizes of Carboflex dressings

Date of recall: 19/03/24

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall- Oestrogel Pump-Pack 750 micrograms/actuation Gel

Besins Healthcare (UK) Ltd has informed the MHRA that a defective pump system was detected in two batches of Oestrogel Pump-Pack 750 micrograms/actuation Gel.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-besins-healthcare-uk-ltd-oestrogel-pump-pack-750-micrograms-slash-actuation-gel-estradiol-el-24-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2a4a39f7-3462-4017-8038-15c956ac6096&utm_content=immediately

Further Information

For medical information enquiries please contact the Besins Healthcare UK Ltd Medical Information via email besins@eu.propharmagroup.com or by calling +44 (0)1748 828 789.

For stock control enquiries please contact Besins Healthcare UK Ltd Supply Chain via email supplychain-bhuk@besins-healthcare.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

class 2 recall-Sodiofolin 50 mg/ml, solution for injection/infusion 8ml

medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.

MHRA drug alert date:12/03/24

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-medac-gmbh-t-slash-a-medac-pharma-llp-sodiofolin-50-mg-slash-ml-solution-for-injection-slash-infusion-folinic-acid-400mg-slash-8ml-vial-el-24-a-slash-08?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b4b7a401-8a7a-4596-8818-f021b9fcd1d9&utm_content=immediately)

Further Information

For all medical enquiries, please contact medical information at medac Pharma LLP by email to info@medacpharma.co.uk or by telephone 01786 458086

UPDATE- Field Safety Notice- Viscopaste Bandage 4948 7.5CMX6M

This is an update to the previous field safety notice first distributed 21/12/23

A customer response form is being circulated, if you had received any affected stock please complete and return to the address listed: QA@evolan.se

We have received a Recall from EVOLAN PHARMA on VISCOPASTE BANDAGE 4948 7.5CMX6M

Date of recall: 21st December 2023

MHRA FSN Link: https://www.gov.uk/drug-device-alerts/field-safety-notices-fsns-from-18-to-22-december-2023

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.